GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds
Clinical trial NCT02260609 · COMPLETED
Trial details
- NCT number
- NCT02260609
- Sponsor
- Osiris Therapeutics
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.